Sanofi India Declares ₹75 Interim Dividend, Posts Q3 Results

Sanofi India Limited announced its unaudited financial results for the quarter and nine months ended September 30, 2026. The Board of Directors approved the results and declared an interim dividend of ₹75 per equity share for the financial year 2026. The record date for this dividend is November 5, 2026. The company reported domestic net sales growth of 2% and total net sales growth of 4% for Q3 2026 compared to Q3 2025. The Diabetes portfolio showed 9% growth, with Lantus®, Toujeo®, and Apidra® leading. Profits before tax and exceptional items rose to ₹158 crores from ₹130 crores in the prior year's quarter. The company also highlighted its CSR initiatives, including the KiDS Program and Medical Mobile Units.